THE ORIGINAL TIMELINE. Critical to this answer was 700mg

New Post Public Reply Private Reply Replies (1) Message Board
blafarm Latane #53519
811
Quote:
THE ORIGINAL TIMELINE. Critical to this answer was 700mg dosing safety which came from the interim M/M trial “safety review.”
That is incorrect. The FDA asked for the Integrated Assessment of the CD03 Mono trial that I believe finished in July.

Also incorrect is that there has never been an "interim M/M trial safety review".

And if you're talking about the DSMC safety review of the CD12 S/C trial -- that has nothing to do with the Combo HIV BLA filing, and we have not been notified that the FDA has officially asked for it in that context.

Regarding all of the other timing issues you discuss, which may or may not be correct, I am now bowing out of this topic and will let others, or Dr.NP, provide commentary.

We all have to try harder to get our facts straight.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Indiana Michigan Power Expands Energy Reach with Acquisition

Updated Category News Views 253

I&M Plans for Sustainable Energy Future Indiana Michigan Power (I&M), part of American Electric Power (NASDAQ: AEP), is making significant strides towards bolstering its energy infrastructure. Recently receiving approval from the Indiana Utility Regulatory Commission (IURC) to acquire the Oregon Clean Energy Center, I&M is focused on delivering reliable and affordable...

Continue Reading
Enhance Your Breathing: Discover Naväge's New SaltPods

Updated Category News Views 163

Breathe Easier Every Day with Naväge® SaltPods The new SaltPods from Naväge feature essential oils combined with saline solution to amplify the nasal rinsing experience and support better breathing throughout the day. Introducing Innovative Nasal Rinsing Solutions Naväge®, a trusted leader in drug-free nasal care, has introduced an exciting addition to wellness...

Continue Reading
O2Gold Increases Financing While Finalizing Quebec Acquisition

Updated Category News Views 185

O2Gold Updates on Major Acquisition and Financing Strategy O2Gold Inc. (NASDAQ: OTGO) is excited to share recent developments regarding its acquisition of a gold mining exploration property in Quebec. This deal involves purchasing all outstanding shares of Quebec Aur Ltd., a move aligned with O2Gold's vision of expanding its mining portfolio. Details on the Acquisition...

Continue Reading
SKYX Technologies Secures $4 Million Preferred Stock Funding

Updated Category News Views 254

SKYX Technologies Secures Significant Funding for Growth MIAMI — SKYX (NASDAQ: SKYX), a leader in smart home platform technologies, has made headlines by securing approximately $4 million in preferred stock funding. This investment comes from strategic investors who purchased shares at a value of $2.00 each. This move is part of a larger financing round, bringing the...

Continue Reading
Coinbase CEO Armstrong's Recent Share Sale Shakes Market

Updated Category News Views 145

Coinbase CEO's Share Sale Influences Market Dynamics Coinbase Global Inc (NASDAQ: COIN) recently experienced a notable decline from its three-year high. This shift occurred following the announcement that CEO Brian Armstrong sold approximately $300 million worth of shares, marking the second major share sale in November. Investors closely follow such transactions, as they...

Continue Reading